Skip to main content
EVIDENCE OF HARM
A documentary exposing the devastating effects of dental mercury on patients, dental staff and the global environment.
FOR IMMEDIATE RELEASE
Do No Harm, LLC, the production company behind Evidence of Harm, has announced that its independent film will have a week long theatrical run in New York and Los Angeles at the following venues.
October 14th - 20th
IFC Center Theater
323 Sixth Avenue at West Third Street
New York, NY 10014
October 23rd - 29th
Laemmle Theater, Music Hall
9036 Wilshire Blvd.
Beverly Hills, CA 90211
Evidence of Harm follows the lives of three health advocates as they struggle to inform the federal government and public that vast amounts of mercury vapor and particulate matter are being released during the removal of “silver” amalgam dental fillings. When the fillings containing 50% mercury are heated by the friction of a dentist’s drill, toxic mercury vapors are released that are invisible, colorless and odorless.
“Exposure to these toxic vapors is a grave concern as published research shows they contribute to a host of adverse health symptoms,” said biochemist Boyd Haley, PhD.
Haley went on to explain, “We have visually demonstrated the mercury vapors generated during routine dental procedures and this shocking footage reveals the peak levels of mercury released during an amalgam removal are vastly higher than limits at which people are evacuated from buildings due to a thermometer breaking."
“I've never seen levels of mercury this high,” says Alex Hummel, a professional with Mercury Instruments USA, who measured the levels of the toxic vapor during the demonstration.
While the manufacturers of amalgam have never proven the safety of their product, the Food and Drug Administration (FDA) allows the product to be sold, and promotes it as safe. Since dental professionals are not taught about the toxicity of mercury amalgam nor of the hazardous vapors it emits, they are unaware of occupational safety regulations mandating that employees be informed about and protected from toxic exposures.
Government reviews of mercury have found its toxic effects are broad, variable, idiosyncratic, and often delayed. Neurological problems, cardiovascular disease, kidney dysfunction, and many other disorders have been linked to mercury.
The team behind the documentary invites the general public to attend the showings of Evidence of Harm in New York and Los Angeles.
This groundbreaking documentary was created by Randall Moore, to raise awareness about the devastating effects of toxic mercury amalgam dental fillings on patients, dental staff and the global environment.
The Michael Russel Group
Cumulative Risk Assessment & Joint Toxicity: Mercury Vapor, Methyl Mercury & Lead
Evidence of Harm + Bonus Material –
Cumulative Risk Assessment & Joint Toxicity: Mercury Vapor, Methyl Mercury & Lead.
Mark Richardson PhD. 2010
Concurrent exposure to Pb, MeHg and Hg0 does occur in the US population. A large proportion
- 1/3rd - of the US population is concurrently exposed to Hg0, methyl Hg and Pb on a daily basis.
All of these substances share the following characteristics:
• All are absorbed in large proportion into systemic circulation;
• All cross the blood-brain and placental barriers;
• All cause neurological toxicity;
• Exposure to all of these substances currently exceed individual reference exposure
levels for many in the US population.
85.7 million Americans currently exceed the California EPA’s reference blood Pb level of 1 ug
Pb per deciliter of blood (1 ug/dL or 10 ug/L). For Hg0, 101.5 million Americans currently
exceed the urine Hg concentration associated with the reference exposure level of 0.06 ug/m3
recently developed in Canada. For methyl Hg, 1.8 million Americans exceed the reference
blood level of 8 ug/L established in Canada for protection or neurological outcomes, particularly
relating to neurodevelopmental effects in the fetus.
The weight of available evidence suggests that risks posed by concurrent exposure to combinations of these 3 substances should be assessed as additive.